Premium
Immune thrombocytopenic purpura in Hodgkin disease
Author(s) -
Hassidim Kamran,
McMillan Robert,
Conjalka Michael S.,
Morrison John
Publication year - 1979
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.2830060207
Subject(s) - thrombocytopenic purpura , medicine , immune system , disease , immunology , pathology
Immune thrombocytopenic purpura is rarely seen in Hodgkin disease and the presence of platelet‐associated antibody has not been previously reported in these patients. A patient with Hodgkin disease is described who developed a destructive thrombocytopenia demonstrated by shortened platelet survival. In conjunction with his thrombocytopenia, he had marked elevation of platelet‐associated immunoglobulin G levels (nanograms IgG per 10 9 platelets: 15,187 prior to splenectomy and 71,130 and 81,900 after surgery). Mean values (± SD) of control subjects averaged 1,975 ± 381 and four patients with Hodgkin disease and normal platelet counts had levels ranging from 1,581 to 4,011. We suggest that this patient had immune‐mediated thrombocytopenia; whether the increase in platelet‐associated immunoglobulin G was due to antiplatelet antibody or to adsorbed or phagocytosed immune complexes cannot be demonstrated by these studies. The platelet‐associated immunoglobulin G test may be useful in evaluating these patients.